"Avoidable Deaths" - Union for International Cancer Control
"Back to Basics: The Concept of HRQL Under a Magnifying Glass" - EORTC Quality of Life Group
"Bald for a Cause" initiative - UWC Dilijan College
Othman Al-Sawaf: Surrogacy of endpoints in 1L CLL trials
Robin Vicken Ohannessian: I am now an Advisor Caraxel AI
Feng Roger Luo: Primary results from a Phase 2 clinical trial evaluating ZYNLONTA® in Chinese patients with relapsed or refractory DLBCL
UICC joined the Commonwealth Secretariat and the Lancet Oncology Commission in London
10 Posts not to miss from the 2025 Texas Lung Cancer Conference – Dr. Estela Rodriguez
Lisa Kaufman: BioVoice discusses Parexel's new "Advancing Precision Oncology" report
